For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Dupont Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 15

Trademarks = 1

Forward Citations = 227

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Robert J Chorvat (4 out of 48 patents)

James Peter Beck (4 out of 13 patents)

Paul Joseph Gilligan (4 out of 47 patents)

4. Rajagopal Bakthavatchalam (2 out of 40 patents)

5. Richard Eric Olson (2 out of 118 patents)

6. Argyrios Georgios Arvanitis (2 out of 13 patents)

7. Douglas G Batt (1 out of 54 patents)

8. Michael J Orwat (1 out of 43 patents)

9. John Wityak (1 out of 49 patents)

10. Soo Sung Ko (1 out of 41 patents)

11. Zhe Wang (1 out of 74 patents)

12. Carl Henry Behrens (1 out of 13 patents)

13. Matthew A Curry (1 out of 6 patents)

14. Parthasarathi Rajagopalan (1 out of 13 patents)

15. Ronald L Magolda (1 out of 14 patents)

15 patents: Sort by Forward Citations

1. 6544417 - Low binding liquid retaining and filtering device (2003-04-08),

2. 6218386 - A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor (2001-04-17),

3. 6136809 - Azolo triazines and pyrimidines (2000-10-24),

4. 6130231 - Integrin receptor antagonists (2000-10-10),

5. 6124463 - Benzimidazoles as corticotropin release factor antagonists (2000-09-26),

6. 6124302 - 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse (2000-09-25),

7. 6124300 - Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives (2000-09-26),

8. 6110910 - Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as (2000-08-29),

9. 6107300 - Arylamino fused pyrimidines (2000-08-22),

10. 6107294 - Thiazolo[4,5-d]pyrimidines and pyridines as corticotropin releasing (2000-08-22),

11. 6060491 - 6-membered aromatics as factor Xa inhibitors (2000-05-09),

12. 6060478 - Azolo triazines and pyrimidines (2000-05-09),

13. 6056958 - Method of treatment of arterial and venous thromboembolic disorders (2000-05-02),

14. 6054597 - Processes and intermediates for the preparation of cyclic urea HIV (2000-04-25),

15. 6049019 - Process for the preparation of cyclopropylacetylene (2000-04-11),

Company Overview

Dupont Pharmaceuticals, Inc., based in Wilmington, Delaware, is a leading innovator in the pharmaceutical sector, focusing on the development and manufacturing of advanced therapeutic solutions. The company specializes in a diverse range of medical applications, including biopharmaceuticals and specialty medicines, aimed at addressing critical health challenges. With a commitment to research and development, Dupont leverages cutting-edge technologies to enhance patient care and improve health outcomes across various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#255 in Wilmington, DE

#330 in Delaware

#21,068 in US

#39,959 in the World

Wilmington, DE, United States of America

Dupont Pharmaceuticals, Inc.

Forward Citations = 227

32 inventors:

Robert J Chorvat (4 out of 48 patents)

James Peter Beck (4 out of 13 patents)

Paul Joseph Gilligan (4 out of 47 patents)

4. Rajagopal Bakthavatchalam (2 out of 40 patents)

5. Richard Eric Olson (2 out of 118 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dupont Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/dupont-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…